|
|
|
|
LEADER |
02853nam a22003375i 4500 |
001 |
978-3-642-71125-1 |
005 |
20191027032821.0 |
007 |
cr nn 008mamaa |
008 |
121227s1986 gw | s |||| 0|eng d |
020 |
|
|
|a 9783642711251
|
024 |
7 |
|
|a 10.1007/978-3-642-71125-1
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Primary Hypertension
|b Basic Mechanisms and Therapeutic Implications /
|c edited by Werner Kaufmann, Gerd Bönner, Robert Lang, Karl A. Meurer.
|
250 |
|
|
|a 1st ed. 1986.
|
260 |
# |
# |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 1986.
|
300 |
|
|
|a XII, 240 p. 13 illus.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Critical Review of Pathogenesis of Primary Hypertension -- Sodium Chloride and Blood Pressure -- Non-Modulating Essential Hypertension: A Subset with Sodium Sensitivity -- Vasodepressor Hormones (Kinins) in Blood Pressure Regulation -- Peripheral Adrenergic Mechanisms in Primary Hypertension -- Neural Transmitters and Central Mechanisms in Primary Hypertension -- Brain Peptides in Cardiovascular Regulation -- Critical Evaluation of Basic Mechanisms of Primary Hypertension. Round Table Discussion -- Principal Objectives of Antihypertensive Treatment -- Treatment of Vascular Damage in Experimental Malignant Hypertension with Nifedipine and Its Calcium-Antagonistic Dihydropyridine Derivatives -- Trends in Arteriosclerosis in Treated and Untreated Hypertensive Patients -- Changes in Brain Blood Flow and Organ Function Following Treatment of Primary Hypertension -- Changes in Hypertrophy by Treatment in Hypertension: Results of Experimental Research -- Reversal of Left Ventricular and Coronary Hypertrophy Following Antihypertensive Treatment -- The Use of the Dynamic Spatial Reconstructor to Study Renal Function -- Critical Review of Antihypertensive Pharmacotherapy -- Cardiovascular Intervention Studies: Problems and Perspectives -- Indications for Antihypertensive Treatment -- Rationale for Established Antihypertensive Treatment -- Calcium Channel Blockers in the Treatment of Hypertension -- Converting Enzyme Inhibitors in the Treatment of Hypertension and of Cardiac Failure -- Serotonin, Serotonergic Antagonists, and Hypertension -- Critical Evaluation of Antihypertensive Pharmacotherapy. Round Table Discussion.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Cardiology.
|
650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Cardiology.
|
700 |
1 |
|
|a Kaufmann, Werner.
|e editor.
|
700 |
1 |
|
|a Bönner, Gerd.
|e editor.
|
700 |
1 |
|
|a Lang, Robert.
|e editor.
|
700 |
1 |
|
|a Meurer, Karl A.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-71125-1
|